Inherent Biosciences, Inc.’s cover photo
Inherent Biosciences, Inc.

Inherent Biosciences, Inc.

Biotechnology Research

Salt Lake City, UT 1,312 followers

Pioneering epigenetic medicine for complex diseases

About us

Inherent Biosciences is pioneering epigenetic medicine for complex diseases. Gene dysregulation, a hallmark of complex disease, has been difficult to detect and treat, until now... Our epigenetic platform detects dysregulation across multiple genes and related pathways. We're pioneering a new category of diagnostics and therapeutics that leverage epigenetics, biology's inherent mechanism for gene regulation, to radically transform how we diagnose and treat complex diseases like infertility, autoimmune disease, autism, and other complex diseases. Our first products help patients suffering from infertility. See our first product at: pathfertility.com

Website
http://www.inherentbio.com
Industry
Biotechnology Research
Company size
2-10 employees
Headquarters
Salt Lake City, UT
Type
Privately Held
Founded
2019

Employees at Inherent Biosciences, Inc.

View 12 employees at Inherent Biosciences, Inc.

or

By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.

See all employees

Locations

Updates

  • Inherent Biosciences, Inc. reposted this

    For all my Boston friends - we need your help!! Please see below. Path Fertility Inherent Biosciences, Inc.

    View profile for Kirk Macolini

    President at InteliSpark, LLC, SBIR & STTR Expert (>$525,000,000 in non-dilutive funding secured)

    SBIR Reauthorization Update: Today, we need everyone to call Senator Edward Markey's Washington office (202) 224-2742 and urge the Markey team to accept the bi-partisan compromise and stop the carnage in the American start-up ecosystem. Ask Senator Markey to put start-ups before donors and lobbyists. Here are the basic facts: There is a deal that has bipartisan support and five of the 'Six Corners' have signed off on. 'Six Corners' is the Majority and Minority leadership of the House Small Business Committee, the Senate Small Business and Entrepreneurship Committee, and the House Science, Space, and Technology Committee. The lone holdout is Senator Ed Markey. The deal would require agencies to set a limit on number of proposals a company can submit. Agencies ALREADY have that power! For instance, NSF allows an organization to submit only a single proposal per submission cycle. The new law would go from ‘may’ set a limit to ‘must’ set a limit. Given that most agencies have opted not use the power they already have, it is unlikely they will set strict limits. Yet, somehow even this minor reform is unacceptable to the biggest abusers of the SBIR system. Three of the largest SBIR Mills (Physical Sciences (1,728 SBIR awards worth over $650,000,000), Triton Systems (906 SBIR awards worth over $365,000,000), and Creare (1,371 SBIR awards worth over $495,000,000)) are spending hundreds of thousands of dollars in lobbying effort to grant them unlimited perpetual access to SBIR funds. Further, Physical Sciences CEO and President William Marinelli, Triton System Executive Vice President Ken Mahmud, and Creare Vice President, Principal Engineer & Partner Jay Rozzi are all Markey donors.  The lack of authorization is causing severe carnage in the start-up ecosystem. Given that Massachusetts is a hub of innovation and start-up activity, it is shocking that that Ed Markey is prioritizing donors and lobbyists over his own constituents. I guess he thinks money will be better weapon than serving the people of Massachusetts and the Nation in what what will be a tough primary fight with Seth Moulton. Lisa Goeas Ryan Alban Eric McCrery Maggie Ward Kate Cassling Danielle Fulfs Mary Hrinkevich Vijay Menon Jake Bornstein Neesha Suarez, MPA

  • Inherent Biosciences, Inc. reposted this

    ASRM 2025 in San Antonio, the premier US Reproductive Medicine Congress and Expo, was incredible! The Path Fertility team loved connecting with Providers, Partners and Presenters who continue to drive forward innovation to raise the standard of care in reproductive health, starting with male infertility. Our own Kristin Brogaard, PhD received the 2025 Prize Paper Award from The Society for Male Reproduction and Urology (SMRU) 🙌 Her presentation showed data from a first-of-its-kind, non-invasive test for evaluating men with non-obstructive azoospermia (NOA). Today, many of these patients face invasive micro-TESE procedures with uncertain outcomes. I'm super excited that this test may help identify who is most likely to benefit and also detect underlying genetic syndromes earlier in the diagnostic journey. The remarkable Dr. Dana Siegel, from Shady Grove Fertility, presented a preliminary analysis of a prospective cohort study of our epigenetic sperm quality test (“SpermQT”) showing prediction of pregnancy success rates with ovarian stimulation treatment. Patients with normal SpermQT results had a higher pregnancy rate. 👏 The brilliant Dr. Taylor Kohn, from Baylor College of Medicine, presented a comparison of sperm methylation in infertile men with and without clinical varicocele. This analysis examined differences in sperm methylation signatures associated with one of the most common and treatable male fertility conditions. The findings provide new insight into how epigenetic patterns may contribute to impaired sperm function and how diagnostic precision could personalize treatment decisions, including when to consider surgical repair. 💡 Together, these presentations reinforce a critical message: male fertility is measurable, actionable, and medically significant. They further validate that epigenetic biomarkers can fill longstanding diagnostic gaps and guide more effective, less-invasive care. Additionally, there were many more presentations from incredible clinical researchers and we loved all of the conversations, happy hours, and serendipitous meet-ups with so many wonderful people driving the field of reproductive medicine forward. Let's GO!!

    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image

Similar pages

Browse jobs

Funding